Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...
AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.
The UAB Systems Pharmacology AI Research Center (SPARC), led by Jake Y. Chen, Ph.D., director of SPARC and professor in the Department of Biomedical Informatics and Data Science, has achieved a ...
A new drug discovery paradigm Enki is purpose-built for small-molecule drug discovery (Fig. 1). Fully trained on millions of data points including curated molecular structures, bioactivity profiles ...
Heisenberg is a quantum-informed AI platform developed by Famous Labs to support small-molecule drug discovery. It is designed to help drug discovery teams prioritize synthesis, reduce experimental ...
Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.
ANN ARBOR, Mich. & NEW YORK--(BUSINESS WIRE)--A new partnership between the University of Michigan (U-M) and health care investment firm Deerfield Management Co. will create a company to commercialize ...
Pharmaceutical Technology on MSN
Teijin and Aska Pharmaceutical to co-develop gynaecological drugs
The collaboration intends to improve compound screening by employing CADD and AI technologies.
Recursion Pharmaceuticals RXRX and Schrodinger SDGR are pioneering the use of artificial intelligence (AI) in drug discovery for various indications across different disease areas. They leverage ...
GV Research Platform (GVRP) today announced a strategic distribution partnership with Yurogen Biosystems, a global life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results